Extracellular Matrix and Organ Transplantation

  • J. Ana Coito
  • W. Jerzy Kupiec-Weglinski
  • W. Ronald Busuttil


Extracellular matrix (ECM), a complex structural entity of tissues and blood vessel walls, envisioned for many decades as a “simple passive” support for cells, has far more challenging roles in regulating a number of biological processes, mediated by specific cellular receptors and intracellular signaling pathways’, 2.


Organ Transplantation Chronic Rejection Cardiac Allograft Discoidin Domain Receptor Islet Allograft 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Giancotti, F.G. and E. Ruoslahti (1999). Integrin signaling.Science 2851028.PubMedCrossRefGoogle Scholar
  2. 2.
    Hynes, R.O. (2002). Integrins: Bidirectional, allosteric signaling machines.Cell 110673.PubMedCrossRefGoogle Scholar
  3. 3.
    Gilat, D., L. Cahalon, R. Hershkoviz, and O. Lider (1996). Interplay of T cells and cytokines in the context of enzymatically modified extracellular matrix.Immunol. Today 1716.PubMedCrossRefGoogle Scholar
  4. 4.
    Coito, A.J., L.F. Brown, J.H. Peters, J.W. Kupiec-Weglinski, and W.L.vande (1997). Expression of fibronectin splicing variants in organ transplantation: A differential pattern between rat cardiac allografts and isografts.Am. J. Pathol. 150 1757. PubMedGoogle Scholar
  5. 5.
    Coito, A.J. and J.W. Kupiec-Weglinski (2000). Extracellular matrix proteins in organ transplantation.Transplantation 692465.PubMedCrossRefGoogle Scholar
  6. 6.
    Nagase, H. and J.F. Woessner, Jr. (1999). Matrix metalloproteinases.J. Biol. Chem. 27421491.PubMedCrossRefGoogle Scholar
  7. 7.
    Hynes, R.O. (1986). Fibronectins.Sci. Am. 25442.Google Scholar
  8. 8.
    Yamada, K.M., S. Aota, S.K. Akiyama, and S.E. LaFlamme (1992). Mechanisms of fibronectin and integrin function during cell adhesion and migration.Cold Spring Harb. Symp. Quant. Biol. 57203.PubMedCrossRefGoogle Scholar
  9. 9.
    Hynes, R.O. (1995). Cell adhesion and human disease. Chairman’s introduction.Ciba Found. Symp. 1891.PubMedGoogle Scholar
  10. 10.
    Tamkun, J.W., J.E. Schwarzbauer, and R.O. Hynes (1984). A single rat fibronectin gene generates three different mRNAs by alternative splicing of a complex exon.Proc. Natl. Acad. Sci. USA 815140.PubMedCrossRefGoogle Scholar
  11. 11.
    Kornblihtt, A.R., K. Umezawa, K. Vibe-Pedersen, and F.E. Baralle (1985). Primary structure of human fibronectin: Differential splicing may generate at least 10 polypeptides from a single gene.EMBO J. 41755.PubMedGoogle Scholar
  12. 12.
    Wayner, E.A., A. Garcia-Pardo, M.J. Humphries, J.A. McDonald, and W.G. Carter (1989). Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin.J. Cell Biol. 1091321.PubMedCrossRefGoogle Scholar
  13. 13.
    Vartio, T., L. Laitinen, O. Narvanen, M. Cutolo, L.E. Thornell, L. Zardiet al.(1987). Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues.J. Cell Sci. 88(Pt4), 419.Google Scholar
  14. 14.
    CarnemollaB.E. Balza, A. Siri, L. Zardi, M.R. Nicotra, A. Bigottiet al.(1989). A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors.J. Cell Biol. 1081139.Google Scholar
  15. 15.
    Brown, L.F., D. Dubin, L. Lavigne, B. Logan, H.F. Dvorak, and W.L. van de (1993). Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing. Am.J. Pathol. 142793.PubMedGoogle Scholar
  16. 16.
    Ffrench-Constant, C., L. Van de Water, H.F. Dvorak, and R.O. Hynes (1989). Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat.J. Cell Biol. 109903.PubMedCrossRefGoogle Scholar
  17. 17.
    Mamuya, W.S. and P. Brecher (1992). Fibronectin expression in the normal and hypertrophic rat heart.J. Clin. Invest. 89392.PubMedCrossRefGoogle Scholar
  18. 18.
    Barnes, J.L., E.S. Torres, R.J. Mitchell, and J.H. Peters (1995). Expression of alternatively spliced fibronectin variants during remodeling in proliferative glomerulonephritis.Am. J. Pathol. 1471361.PubMedGoogle Scholar
  19. 19.
    Nickeleit, V., L. Zagachin, K. Nishikawa, J.H. Peters, R.O. Hynes, andR.B.Colvin (1995). Embryonic fibronectin isoforms are synthesized in crescents in experimental autoimmune glomerulonephritis. Am.J. Pathol. 147965.Google Scholar
  20. 20.
    Schwarzbauer, J.E. (1991). Fibronectin: From gene to protein.Curr Opin. Cell Biol. 3786.PubMedCrossRefGoogle Scholar
  21. 21.
    George, E.L., E.N. Georges-Labouesse, R.S. Patel-King, H. Rayburn, and R.O. Hynes (1993). Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin.Development 1191079.PubMedGoogle Scholar
  22. 22.
    Georges-Labouesse, E.N., E.L. George, H. Rayburn, and R.O. Hynes (1996). Mesodermal development in mouse embryos mutant for fibronectin.Dey. Dyn. 207145.CrossRefGoogle Scholar
  23. 23.
    Shimizu, Y., G.A. van Seventer, K.J. Horgan, and S. Shaw (1990). Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin.J. Immunol. 14559.PubMedGoogle Scholar
  24. 24.
    Hauzenberger, D., J. Klominek, and K.G. Sundqvist (1994). Functional specialization of fibronectin-binding beta 1-integrins in T lymphocyte migration.J. Immunol. 153960.PubMedGoogle Scholar
  25. 25.
    Hunter, A.J. and Y. Shimizu (1997). Alpha 4 beta 1 integrin-mediated tyrosine phosphorylation in human T cells: Characterization of Crk-and Fyn-associated substrates (pp.105, 115, and human enhancer of filamentation-1) and integrin-dependent activation of p59fynl. JImmunol. 1594806.PubMedGoogle Scholar
  26. 26.
    Ybarrondo, B., A.M. O’Rourke, A.A. Brian, and M.F. Mescher (1994). Contribution of lymphocyte functionassociated-1/intercellular adhesion molecule-1 binding to the adhesion/signaling cascade of cytotoxic T lymphocyte activation.J. Exp. Med. 179359.PubMedCrossRefGoogle Scholar
  27. 27.
    Ostergaard, H.L. and E.A. Ma (1995). Fibronectin induces phosphorylation of a 120-kDa protein and synergizes with the T cell receptor to activate cytotoxic T cell clones.Eur. J. Immunol. 25252.PubMedCrossRefGoogle Scholar
  28. 28.
    HauzenbergerD.J. Klominek, and K.G. Sundqvist (1994). Functional specialization of fibronectin-binding beta 1-integrins in T lymphocyte migration.J. Immunol. 153960.PubMedGoogle Scholar
  29. 29.
    Erickson, H.P. (1993). Tenascin-C, tenascin-R and tenascin-X: A family of talented proteins in search of functions.Curr. Opin. Cell Biol. 5869.PubMedCrossRefGoogle Scholar
  30. 30.
    Oberhauser, A.F., P.E. Marszalek, H.P. Erickson, and J.M. Fernandez (1998). The molecular elasticity of the extracellular matrix protein tenascin.Nature 393181.PubMedCrossRefGoogle Scholar
  31. 31.
    Chiquet-Ehrismann, R., C. Hagios, and K. Matsumoto (1994). The tenascin gene family.Perspect. Dey. Neurobiol. 23.Google Scholar
  32. 32.
    Mackie, E.J. (1997). Molecules in focus: Tenascin-C.Int. J. Biochem. Cell Biol. 291133.PubMedCrossRefGoogle Scholar
  33. 33.
    Chilosi, M., M. Lestani, A. Benedetti, L. Montagna, S. Pedron, A. Scarpaet al.(1993). Constitutive expression of tenascin in T-dependent zones of human lymphoid tissues.Am. J. Pathol. 1431348.PubMedGoogle Scholar
  34. 34.
    Mackie, E.J., W. Halfter, and D. Liverani (1988). Induction of tenascin in healing wounds.J. Cell Biol. 1072757.PubMedCrossRefGoogle Scholar
  35. 35.
    Erickson, H.P. and M.A. Bourdon (1989). Tenascin: An extracellular matrix protein prominent in specialized embryonic tissues and tumors.Annu. Rev. Cell Biol. 571.PubMedCrossRefGoogle Scholar
  36. 36.
    Jones, P.L. and F.S. Jones (2000). Tenascin-C in development and disease: Gene regulation and cell function.Matrix Biol. 19581.PubMedCrossRefGoogle Scholar
  37. 37.
    Ruegg, C.R., R. Chiquet-Ehrismann, and S.S. Alkan (1989). Tenascin, an extracellular matrix protein, exerts immunomodulatory activities.Proc. Natl. Acad. Sci. USA 867437.PubMedCrossRefGoogle Scholar
  38. 38.
    Hemesath, T.J., L.S. Marton, and K. Stefansson (1994). Inhibition of T cell activation by the extracellular matrix protein tenascin.J. Immunol. 1525199.PubMedGoogle Scholar
  39. 39.
    Hauzenberger, D., P. Olivier, D. Gundersen, and C. Ruegg (1999). Tenascin-C inhibits betal integrin-dependent T lymphocyte adhesion to fibronectin through the binding of its fnIII 1–5 repeats to fibronectin.Eur. J. Immunol. 291435.PubMedCrossRefGoogle Scholar
  40. 40.
    Gundersen, D., C. Tran-Thang, B. Sordat, F. Mourali, and C. Ruegg (1997). Plasmin-induced proteolysis of tenascin-C: Modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering.J. Immunol. 1581051.PubMedGoogle Scholar
  41. 41.
    Clark, R.A., H.P. Erickson, and T.A. Springer (1997). Tenascin supports lymphocyte rolling.J. Cell Biol. 137755.PubMedCrossRefGoogle Scholar
  42. 42.
    Timpl, R., H. Rohde, P.G. Robey, S.I. Rennard, J.M. Foidart, and G.R. Martin (1979). Laminin-a glycoprotein from basement membranes.J. Biol. Chem. 2549933.PubMedGoogle Scholar
  43. 43.
    Martin, G.R. and R. Timpl (1987). Laminin and other basement membrane components.Annu. Rev. Cell Biol. 357.PubMedCrossRefGoogle Scholar
  44. 44.
    Rohde, H., G. Wick, and R. Timpl (1979). Immunochemical characterization of the basement membrane glycoprotein laminin.Eur. J. Biochem. 102195.PubMedCrossRefGoogle Scholar
  45. 45.
    Patarroyo, M., K. Tryggvason, and I. Virtanen (2002). Laminin isoforms in tumor invasion, angiogenesis and metastasis.Semin. Cancer Biol. 12197.PubMedCrossRefGoogle Scholar
  46. 46.
    Wei, J., L.M. Shaw, and A.M. Mercurio (1998). Regulation of mitogen-activated protein kinase activation by the cytoplasmic domain of the alpha6 integrin subunit.J. Biol. Chem. 2735903.PubMedCrossRefGoogle Scholar
  47. 47.
    Kupiec-Weglinski, J.W. and M. De Sousa (1991). Lymphocyte traffic is modified in vivo by anti-laminin antibody.Immunology 72312.PubMedGoogle Scholar
  48. 48.
    Lannes-VieiraJ.R. Chammas, D.M. Villa-Verde, d.S.M. Vannier, V. Mello-Coelho, S.J. de Souzaet al.(1993). Extracellular matrix components of the mouse thymic microenvironment. III. Thymic epithelial cells express the VLA6 complex that is involved in laminin-mediated interactions with thymocytes.Int. Immunol. 51421.CrossRefGoogle Scholar
  49. 49.
    De Sousa, M. (1994). Lymphocyte traffic and positioning in vivo: An expanded role for the ECM, the VLA proteins and the cytokines.Pathol. Res. Pract. 190840.PubMedCrossRefGoogle Scholar
  50. 50.
    Imhof, B.A., R. Ruiz, B. Hesse, R. Palacios, and D. Dunon (1991). EA-1, a novel adhesion molecule involved in the homing of progenitor T lymphocytes to the thymus.J. Cell Biol. 1141069.PubMedCrossRefGoogle Scholar
  51. 51.
    Brown, J.C. and R. Timpl (1995). The collagen superfamily.Int. Arch. Allergy Immunol. 107484.PubMedCrossRefGoogle Scholar
  52. 52.
    Timpl, R. and J.C. Brown (1996). Supramolecular assembly of basement membranes.Bioessays 18123.PubMedCrossRefGoogle Scholar
  53. 53.
    Schultz R.M. (1986).Biochemistry with Clinical Correlations.J. Wiley & Sons Inc, London, UK, pp. 75–115.Google Scholar
  54. 54.
    de Fougerolles, A.R., A.G. Sprague, C.L. Nickerson-Nutter, G. Chi-Rosso, P.D. Rennert, H. Gardneret al.(2000). Regulation of inflammation by collagen-binding integrins alpha lbeta1 and alpha2beta1 in models of hypersensitivity and arthritis.J. Clin. Invest. 105721.PubMedCrossRefGoogle Scholar
  55. 55.
    Hynes, R.O. (1996). Targeted mutations in cell adhesion genes: What have we learned from them?Dey. Biol. 180402.CrossRefGoogle Scholar
  56. 56.
    Guan, J.L. and R.O. Hynes (1990). Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor alpha 4 beta 1.Cell 6053.PubMedCrossRefGoogle Scholar
  57. 57.
    Bernier, M.E. and R.R. Lobb (1995). The leukocyte beta 1 integrins.Curr. Opin. Hematol. 261.CrossRefGoogle Scholar
  58. 58.
    Moyano, J.V., B. Carnemolla, C. Dominguez-Jimenez, M. Garcia-Gila, J.P. Albar, R Sanchez-Aparicioet al.(1997). Fibronectin type BI5 repeat contains a novel cell adhesion sequence, KLDAPT, which binds activated alpha4betal and alpha4beta7 integrins.J. Biol. Chem. 27224832.PubMedCrossRefGoogle Scholar
  59. 59.
    Liao, Y.F., P.J. Gotwals, V.E. Koteliansky, D. Sheppard, and W.L. van de (2002). The EIIIA segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing.J. Biol. Chem. 27714467.PubMedCrossRefGoogle Scholar
  60. 60.
    Osborn, L., C. Vassallo, B.G. Browning, R. lizard, D.O. Haskard, C.D. Benjaminet al.(1994). Arrangement of domains, and amino acid residues required for binding of vascular cell adhesion molecule-1 to its counter-receptor VLA-4 (alpha 4 beta 1).J. Cell Biol. 124601.PubMedCrossRefGoogle Scholar
  61. 61.
    Berlin, C., R.F. Bargatze, J.J. Campbell, U.H. von Andrian, M.C. Szabo, S.R. Hasslenet al.(1995). alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow.Cell 80413.PubMedCrossRefGoogle Scholar
  62. 62.
    Sanchez-Aparicio, R, C. Dominguez-Jimenez, and A. Garcia-Pardo (1994). Activation of the alpha 4 beta 1 integrin through the beta 1 subunit induces recognition of the RGDS sequence in fibronectin.J. Cell Biol. 126271.PubMedCrossRefGoogle Scholar
  63. 63.
    Klingemann, H.G. and S. Dedhar (1989). Distribution of integrins on human peripheral blood mononuclear cells.Blood 741348.PubMedGoogle Scholar
  64. 64.
    Postigo, A.A., P. Sanchez-Mateos, A.I. Lazarovits, E Sanchez-Madrid, and M.O. de Landazuri (1993). Alpha 4 beta 7 integrin mediates B cell binding to fibronectin and vascular cell adhesion molecule-1. Expression and function of alpha 4 integrins on human B lymphocytes.J. Immunol. 1512471.PubMedGoogle Scholar
  65. 65.
    Vogel, B.E., G. Tarone, F.G. Giancotti, J. Gailit, and E. Ruoslahti (1990). A novel fibronectin receptor with an unexpected subunit composition (alpha v beta 1).J. Biol Chem. 2655934.PubMedGoogle Scholar
  66. 66.
    Robert, C., R.C. Fuhlbrigge, J.D. Kieffer, S. Ayehunie, R.O. Hynes, G. Chenget al.(1999). Interaction of dendritic cells with skin endothelium: A new perspective on immunosurveillance.J. Exp. Med. 189627.PubMedCrossRefGoogle Scholar
  67. 67.
    ShawL.M.and A.M. Mercurio (1995). Regulation of alpha 6 beta 1 integrin-mediated migration in macrophages.Agents Actions Suppl. 47101.PubMedGoogle Scholar
  68. 68.
    Bohnsack, J.F., S.K. Akiyama, C.H. Damsky, W.A. Knape, and G.A. Zimmerman (1990). Human neutrophil adherence to laminin in vitro. Evidence for a distinct neutrophil integrin receptor for laminin.J. Exp. Med. 1711221.PubMedCrossRefGoogle Scholar
  69. 69.
    Shimizu, Y., G.A. van Seventer, K.J. Horgan, and S. Shaw (1990). Regulated expression and binding of three VLA (beta 1) integrin receptors on T cells.Nature 345250.PubMedCrossRefGoogle Scholar
  70. 70.
    Kern, A., J. Eble, R. Golbik, and K. Kuhn (1993). Interaction of type IV collagen with the isolated integrins alpha 1 beta 1 and alpha 2 beta 1.Eur. J. Biochem. 215151.PubMedCrossRefGoogle Scholar
  71. 71.
    Gullberg, D., K.R. Gehlsen, D.C. Turner, K. Ahlen, L.S. Zijenah, M.J. Barneset al.(1992). Analysis of alpha 1 beta 1, alpha 2 beta 1 and alpha 3 beta 1 integrins in cell-collagen interactions: Identification of conformation dependent alpha 1 beta 1 binding sites in collagen type I.EMBO J. 113865.PubMedGoogle Scholar
  72. 72.
    Shimizu, Y., J.L. Mobley, L.D. Finkelstein, and A.S. Chan (1995). A role for phosphatidylinositol 3-kinase in the regulation of beta 1 integrin activity by the CD2 antigen.J. Cell Biol. 1311867.PubMedCrossRefGoogle Scholar
  73. 73.
    Chan, A.S., J.L. Mobley, G.B. Fields, and Y. Shimizu (1997). CD7-mediated regulation of integrin adhesiveness on human T cells involves tyrosine phosphorylation-dependent activation of phosphatidylinositol 3-kinase.J. Immunol. 159934.PubMedGoogle Scholar
  74. 74.
    Chan, A.S., J.L. Mobley, G.B. Fields, and Y. Shimizu (1997). CD7-mediated regulation of integrin adhesiveness on human T cells involves tyrosine phosphorylation-dependent activation of phosphatidylinositol 3-kinase.J. Immunol. 159934.Google Scholar
  75. 75.
    Kane, L.P., J. Lin, and A. Weiss (2000). Signal transduction by the TCR for antigen.Curr. Opin. Immunol. 12242.PubMedCrossRefGoogle Scholar
  76. 76.
    Weber, C., R. Alon, B. Moser, and T.A. Springer (1996). Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity by CC chemokines in monocytes: Implications for transendothelial chemotaxis.J. Cell Biol. 1341063.PubMedCrossRefGoogle Scholar
  77. 77.
    Carr, M.W., R. Alon, and T.A. Springer (1996). The C-C chemokine MCP-1 differentially modulates the avidity of beta 1 and beta 2 integrins on T lymphocytes.Immunity 4179.PubMedCrossRefGoogle Scholar
  78. 78.
    Carr, M.W., S.J. Roth, E. Luther, S.S. Rose, and T.A. Springer (1994). Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant.Proc. Natl. Acad. Sci. USA 913652.PubMedCrossRefGoogle Scholar
  79. 79.
    Carr, M.W., R. Alon, and T.A. Springer (1996). The C-C chemokine MCP-1 differentially modulates the avidity of beta 1 and beta 2 integrins on T lymphocytes.Immunity 4179.PubMedCrossRefGoogle Scholar
  80. 80.
    Basbaum, C.B. and Z. Werb (1996). Focalized proteolysis: Spatial and temporal regulation of extracellular matrix degradation at the cell surface.Curr. Opin. Cell Biol. 8731.PubMedCrossRefGoogle Scholar
  81. 81.
    Vu, T.H. and Z. Werb (2000). Matrix metalloproteinases: Effectors of development and normal physiology.Genes Dey. 142123.CrossRefGoogle Scholar
  82. 82.
    SatoH.T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamotoet al.(1994). A matrix metalloproteinase expressed on the surface of invasive tumour cells.Nature 37061.PubMedCrossRefGoogle Scholar
  83. 83.
    Owen, C.A. and E.J. Campbell (1999). The cell biology of leukocyte-mediated proteolysis. J.Leukoc. Biol. 65137.PubMedGoogle Scholar
  84. 84.
    Spinale, F. G (2002). Matrix metalloproteinases: Regulation and dysregulation in the failing heart.Circ. Res. 90520.PubMedCrossRefGoogle Scholar
  85. 85.
    English, W.R., X.S. Puente, J.M. Freije, V. Knauper, A. Amour, A. Merryweatheret al.(2000). Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2.J. Biol. Chem. 27514046.PubMedCrossRefGoogle Scholar
  86. 86.
    Kajita, M., Y. Itoh, T. Chiba, H. Mori, A. Okada, H. Kinohet al.(2001). Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration.J. Cell Biol. 153893.PubMedCrossRefGoogle Scholar
  87. 87.
    Bode, W., C. Fernandez-Catalan, F. Grams, F.X. Gomis-Ruth, H. Nagase, H. Tschescheet al.(1999). Insights into MMP-TIMP interactions.Ann. N. Y. Acad. Sci. 87873.PubMedCrossRefGoogle Scholar
  88. 88.
    Stetler-Stevenson, W.G., L.A. Liotta, and D.E. Kleiner, Jr., (1993). Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis.FASEB J. 71434.PubMedGoogle Scholar
  89. 89.
    Mohtai, M., R.L. Smith, D.J. Schurman, Y. Tsuji, F.M. Torti, N.I. Hutchinsonet al.(1993). Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1.J. Clin. Invest. 92179.PubMedCrossRefGoogle Scholar
  90. 90.
    Cawston, T.E., E. Mercer, M. de Silva, and B.L. Hazleman (1984). Metalloproteinases and collagenase inhibitors in rheumatoid synovial fluid.Arthritis Rheum. 27285.PubMedCrossRefGoogle Scholar
  91. 91.
    YoshijiH.S. Kuriyama, J. Yoshii, Y. Ikenaka, R. Noguchi, T. Nakataniet al.(2002). Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse.Hepatology 36850.Google Scholar
  92. 92.
    WielockxB.K. Lannoy, S.D. Shapiro, T. Itoh, S. Itohara, J. Vandekerckhoveet al.(2001). Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy.Nat. Med. 71202.PubMedCrossRefGoogle Scholar
  93. 93.
    Demirci, G., B. Nashan, and R. Pichlmayr (1996). Fibrosis in chronic rejection of human liver allografts: Expression patterns of transforming growth factor-TGFbetal and TGF-beta3.Transplantation 621776.PubMedCrossRefGoogle Scholar
  94. 94.
    Tanabe, S., M. Ueda, Y.S. Han, T. Nakatani, T. Kishimoto, S. Suzukiet al.(1996). Increased tenascin expression is an early feature of the development of transplant renal arteriopathy in humans.Transpl. Int. 9(Suppl 1), S45.PubMedCrossRefGoogle Scholar
  95. 95.
    Mueller, A.R., K.P. Platz, B. Gebauer, C. Schmidt, H. Keck, H. Lobecket al.(1998). Changes at the extra-cellular matrix during acute and chronic rejection in human liver transplantation.Transpl. Int. 11(Suppl 1), S377.PubMedGoogle Scholar
  96. 96.
    Abrass, C.K., A.K. Berfield, C. Stehman-Breen, C.E. Alpers, and C.L. Davis (1999). Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsies [see comments]. Am.J. Kidney Dis. 3311.PubMedCrossRefGoogle Scholar
  97. 97.
    Coito, A.J., J. Binder, M. de Sousa, and J.W. Kupiec-Weglinski (1994). The expression of extracellular matrix proteins during accelerated rejection of cardiac allografts in sensitized rats.Transplantation 57599.PubMedGoogle Scholar
  98. 98.
    Amersi, R, X.D. Shen, C. Moore, J. Melinek, R.W. Busuttil, A.J. Coito (2003). Fibronectin-a4ß1 integrinmediated blockade protects genetically fat zucker rat livers from ischemia/reperfusion injury. Am.J. Pathol. 1621229–1239.PubMedCrossRefGoogle Scholar
  99. 99.
    Jarnagin, W.R., D.C. Rockey, V.E. Koteliansky, S.S. Wang, and D.M. Bissell (1994). Expression of variant fibronectins in wound healing: Cellular source and biological activity of theEIIIAsegment in rat hepatic fibrogenesis.J. Cell Biol. 1272037.PubMedCrossRefGoogle Scholar
  100. 100.
    Coito, A.J., J. Binder, L.F. Brown, M. de Sousa, W.L. van de, and J.W. Kupiec-Weglinski (1995). Anti-TNFalpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats.J. Immunol. 1542949.PubMedGoogle Scholar
  101. 101.
    Roberts, C.J., T.M. Birkenmeier, J.J. McQuillan, S.K. Akiyama, S.S. Yamada, W.T. Chenet al.(1988). Transforming growth factor beta stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts.J. Biol. Chem. 2634586.PubMedGoogle Scholar
  102. 102.
    Ignotz, R.A., T. Endo, and J. Massague (1987). Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta.J. Biol Chem. 2626443.PubMedGoogle Scholar
  103. 103.
    Molossi, S., N. Clausell, and M. Rabinovitch (1995). Reciprocal induction of tumor necrosis factor-alpha and interleukin-1 beta activity mediates fibronectin synthesis in coronary artery smooth muscle cells.J. Cell Physiol. 16319.PubMedCrossRefGoogle Scholar
  104. 104.
    Clausell, N., S. Molossi, S. Sett, and M. Rabinovitch (1994). In vivo blockade of tumor necrosis factor-alpha in cholesterol-fed rabbits after cardiac transplant inhibits acute coronary artery neointimal formation.Circulation 892768.PubMedCrossRefGoogle Scholar
  105. 105.
    Coito, A.J., K. Onodera, H. Kato, R.W. Busuttil, and J.W. Kupiec-Weglinski (2000). Fibronectin-mononuclear cell interactions regulate type 1 helper T cell cytokine network in tolerant transplant recipients. Am.J. Pathol. 1571207.PubMedCrossRefGoogle Scholar
  106. 106.
    McCarthy, J.B., B.V. Vachhani, S.M. Wahl, D.S. Finbloom, and G.M. Feldman (1997). Human monocyte binding to fibronectin enhances IFN-gamma-induced early signaling events.J. Immunol. 1592424.PubMedGoogle Scholar
  107. 107.
    Brunmark, A. and A.M. O’Rourke (1997). Augmentation of mature CD4+ T cell responses to isolated antigenic class II proteins by fibronectin and intercellular adhesion molecule-1.J. Immunol. 1591676.PubMedGoogle Scholar
  108. 108.
    Hershkoviz, R., D. Gilat, S. Miron, Y.A. Mekori, D. Aderka, D. Wallachet al.(1993). Extracellular matrix induces tumour necrosis factor-alpha secretion by an interaction between resting rat CD4+ T cells and macrophages.Immunology 7850.PubMedGoogle Scholar
  109. 109.
    Riederer, I., S.D. Silva-Barbosa, M.L. Rodrigues, and W. Savino (2002). Local antilaminin antibody treatment alters the rejection pattern of murine cardiac allografts: Correlation between cellular infiltration and extracellular matrix.Transplantation74, 1515.PubMedCrossRefGoogle Scholar
  110. 110.
    Lohr, K.M., C.A. Kurth, D.L. Xie, J.M. Seyer, and G.A. Homandberg (1990). The amino-terminal 29- and 72-Kd fragments of fibronectin mediate selective monocyte recruitment.Blood 762117.PubMedGoogle Scholar
  111. 111.
    Dorent, R., J.L. Beaudeux, S. Tezenas, J.J. Ghossoub, A.L. Roussouliere, P. Legeret al.(2000). Circulating levels of matrix metalloproteinases in heart transplant recipients.Transplant. Pmc. 322750.CrossRefGoogle Scholar
  112. 112.
    Soccal, P.M., Y. Gasche, J.C. Pache, O. Schneuwly, D.O. Slosman, D.R. Morelet al.(2000). Matrix metalloproteinases correlate with alveolar-capillary permeability alteration in lung ischemia-reperfusion injury.Transplantation 70998.PubMedCrossRefGoogle Scholar
  113. 113.
    Lindsey, M., K. Wedin, M.D. Brown, C. Keller, A.J. Evans, J. Smolenet al.(2001). Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/ reperfusion.Circulation 1032181.PubMedCrossRefGoogle Scholar
  114. 114.
    Yamani, M.H., E.M. Tuzcu, R.C. Starling, N.B. Ratliff, Y. Yu, D.G. Vinceet al.(2002). Myocardial ischemic injury after heart transplantation is associated with upregulation of vitronectin receptor (alpha(v)beta3), activation of the matrix metalloproteinase induction system, and subsequent development of coronary vasculopathy.Circulation 1051955.PubMedCrossRefGoogle Scholar
  115. 115.
    Moore, C., X.D. Shen, F. Amersi, J.W. Kupiec-Weglinski, R.W. Busuttil, and A.J. Coito (2002). Blockade of adhesive interactions protects genetically fat zucker rat livers from ischemia/reperfusion injury by regulating metalloproteinase-9 expression/activation.Am. J. Transpl. 2156 (ABS).Google Scholar
  116. 116.
    Cataldo, D.D., K.G. Tournoy, K. Vermaelen, C. Munaut, J.M. Foidart, R. Louiset al.(2002). Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation.Am. J. Pathol. 161491.PubMedCrossRefGoogle Scholar
  117. 117.
    Hines, K.L., A.B. Kulkarni, J.B. McCarthy, H. Tian, J.M. Ward, M. Christet al.(1994). Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice.Pmc. Natl. Acad. Sci. USA 915187.CrossRefGoogle Scholar
  118. 118.
    Wahl, S.M., J.B. Allen, K.L. Hines, T. Imamichi, A.M. Wahl, L.T. Furchtet al.(1994). Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment.J. Clin. Invest. 94655.PubMedCrossRefGoogle Scholar
  119. 119.
    Coito, A.J., S. Korom, E. Graser, H.D. Volk, W.L. van de, and J.W. Kupiec-Weglinski (1998). Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients: I. Treatment with connecting segment-1 peptides prevents acute rejection by suppressing intragraft mononuclear cell accumulation, endothelial activation, and cytokine expression.Transplantation 65699.PubMedCrossRefGoogle Scholar
  120. 120.
    Molossi, S., M. Elices, T. Arrhenius, and M. Rabinovitch (1995). Lymphocyte transendothelial migration toward smooth muscle cells in interleukin-1 beta-stimulated co-cultures is related to fibronectin interactions with alpha 4 beta 1 and alpha 5 beta 1 integrins.J. Cell Physiol. 164620.PubMedCrossRefGoogle Scholar
  121. 121.
    Yang, H., T.B. Issekutz, and J.R.J. Wright (1995). Prolongation of rat islet allograft survival by treatment with monoclonal antibodies against VLA-4 and LFA-1.Transplantation 6071.PubMedCrossRefGoogle Scholar
  122. 122.
    Stegall, M.D., P.G. Dean, D. Ninova, A.J. Cohen, G.M. Shepard, C. Gupet al.(2001). Alpha4 integrin in islet allograft rejection.Transplantation 711549.PubMedCrossRefGoogle Scholar
  123. 123.
    Elices, M.J., L. Osborn, Y. Takada, C. Crouse, S. Luhowskyj, M.E. Hemleret al.(1990). VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.Cell 60577.PubMedCrossRefGoogle Scholar
  124. 124.
    Makarem, R., P. Newham, J.A. Askari, L.J. Green, J. Clements, M. Edwardset al.(1994). Competitive binding of vascular cell adhesion molecule-1 and the HepIl/IIICS domain of fibronectin to the integrin alpha 4 beta 1.J. Biol. Chem. 2694005.PubMedGoogle Scholar
  125. 125.
    Orosz, C.G., R.G. Ohye, R.P. Pelletier, A.M. Van Buskirk, E. Huang, C. Morganet al.(1993). Treatment with anti-vascular cell adhesion molecule 1 monoclonal antibody induces long-term murine cardiac allograft acceptance.Transplantation 56453.PubMedCrossRefGoogle Scholar
  126. 126.
    dos, S.R., M.A. Rossi, J.L. Laus, J.S. Silva, W. Savino, and J. Mengel (1992). Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected withTrypanosoma cruzi. J. Exp. Med. 17529.CrossRefGoogle Scholar
  127. 127.
    Silva-Barbosa, S.D., V. Cotta-de-Almeida, I. Riederer, J. De Meis, M. Dardenne, A. Bonomoet al.(1997). Involvement of laminin and its receptor in abrogation of heart graft rejection by autoreactive T cells fromTrypanosomacruzi-infected mice.J. Immunol. 159997.PubMedGoogle Scholar
  128. 128.
    Seiter, S., B. Weber, W. Tilgen, and M. Zoller (1998). Down-modulation of host reactivity by anti-CD44 in skin transplantation.Transplantation 66778.PubMedCrossRefGoogle Scholar
  129. 129.
    Knoflach, A., C. Magee, M.D. Denton, K.S. Kim, R. Buelow, W.W. Hancocket al.(1999). Immunomodulatory functions of hyaluronate in the LEW-to-F344 model of chronic cardiac allograft rejection.Transplantation 67909.PubMedCrossRefGoogle Scholar
  130. 130.
    DeGrendele, H.C., P. Estess, L.J. Picker, and M.H. Siegelman (1996). CD44 and its ligand hyaluronate mediate rolling under physiologic flow: A novel lymphocyte-endothelial cell primary adhesion pathway.J. Exp. Med. 1831119.PubMedCrossRefGoogle Scholar
  131. 131.
    Estess, P., A. Nandi, M. Mohamadzadeh, and M.H. Siegelman (1999). Interleukin 15 induces endothelial hyaluronan expression in vitro and promotes activated T cell extravasation through a CD44-dependent pathway in vivo.J. Exp. Med. 1909.PubMedCrossRefGoogle Scholar
  132. 132.
    DeGrendele, H.C., P. Estess, and M.H. Siegelman (1997). Requirement for CD44 in activated T cell extravasation into an inflammatory site.Science 278672.PubMedCrossRefGoogle Scholar
  133. 133.
    Giachelli, C.M., D. Lombardi, R.J. Johnson, C.E. Murry, and M. Almeida (1998). Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo.Am. J. Pathol. 152353.PubMedGoogle Scholar
  134. 134.
    Madri, J.A. and H. Furthmayr (1980). Collagen polymorphism in the lung. An immunochemical study of pulmonary fibrosis.Hum. Pathol. 11353.PubMedCrossRefGoogle Scholar
  135. 135.
    Yasufuku, K., K.M. Heidler, K.A. Woods, G.N. Smith, Jr., O.W. Cummings, T. Fujisawaet al.(2002). Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance.Transplantation 73500.PubMedCrossRefGoogle Scholar
  136. 136.
    Hague, M.A., T. Mizobuchi, K. Yasufuku, T. Fujisawa, R.R. Brutkiewicz, Y. Zhenget al.(2002). Evidence for immune responses to a self-antigen in lung transplantation: Role of type V collagen-specificTcells in the pathogenesis of lung allograft rejection.J. Immunol. 1691542.Google Scholar
  137. 137.
    Vogel, W., G.D. Gish, E Alves, and T. Pawson (1997). The discoidin domain receptor tyrosine kinases are activated by collagen.Mol. Cell 113.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • J. Ana Coito
    • 1
  • W. Jerzy Kupiec-Weglinski
    • 1
  • W. Ronald Busuttil
    • 1
  1. 1.The Dumont-UCLA Transplant Center, Division of Liver and Pancreas TransplantationDavid Geffen School of Medicine at UCLALos AngelesUSA

Personalised recommendations